Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2020

Open Access 01-12-2020 | Borderline Personality Disorder | Study protocol

INdividual Vocational and Educational Support Trial (INVEST) for young people with borderline personality disorder: study protocol for a randomised controlled trial

Authors: Andrew M. Chanen, Katie Nicol, Jennifer K. Betts, Gary R. Bond, Cathrine Mihalopoulos, Henry J. Jackson, Katherine N. Thompson, Martina Jovev, Hok Pan Yuen, Gina Chinnery, Judith Ring, Kelly Allott, Louise McCutcheon, Ashleigh P. Salmon, Eoin Killackey

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

The clinical onset of borderline personality disorder (BPD) usually occurs in young people (aged 12–25 years) and commonly leads to difficulty achieving and maintaining vocational (education and/or employment) engagement. While current psychosocial interventions lead to improvements in psychopathology, they have little effect upon functioning. Individual Placement and Support (IPS) is a client-driven model that assists individuals with severe mental illness to engage with education and/or employment appropriate to their personal goals, and that provides ongoing support to maintain this engagement. The objective of the INdividual Vocational and Educational Support Trial (INVEST) is to evaluate the effectiveness of adding IPS to an evidence-based early intervention programme for BPD, with the aim of improving vocational outcomes.

Methods/design

INVEST is a single-blind, parallel-groups, randomised controlled trial (RCT). The randomisation is stratified by gender and age and uses random permuted blocks. The interventions are 39 weeks of either IPS, or ‘usual vocational services’ (UVS). Participants will comprise 108 help-seeking young people (aged 15–25 years) with three or more DSM-5 BPD features and a desire to study or work, recruited from the Helping Young People Early (HYPE) early intervention programme for BPD at Orygen, in Melbourne, Australia. All participants will receive the HYPE intervention. After baseline assessment, staff who are blind to the intervention group allocation will conduct assessments at 13, 26, 39 and 52 weeks. At the 52-week primary endpoint, the primary outcome is the number of days in mainstream education/employment since baseline. Secondary outcomes include the cost-effectiveness of the intervention, quality of life, and BPD severity.

Discussion

Current treatments for BPD have little impact on vocational outcomes and enduring functional impairment is prevalent among this patient group. IPS is a targeted functional intervention, which has proven effective in improving vocational outcomes for adults and young people with psychotic disorders. This trial will investigate whether IPS is effective for improving vocational (employment and educational) outcomes among young people with subthreshold or full-syndrome BPD.

Trial registration

Australian New Zealand Clinical Trials Registry, ID: ACTRN12619001220​156. 13 September 2019.
Literature
1.
Gunderson JG, Herpertz SC, Skodol AE, Torgersen S, Zanarini MC. Borderline personality disorder. Nat Rev Dis Primers. 2018;4:18029.PubMed
2.
Chanen AM, Sharp C, Hoffman P, Global Alliance for Prevention and Early Intervention for Borderline Personality Disorder. Prevention and early intervention for borderline personality disorder: a novel public health priority. World Psychiatry. 2017;16(2):215–6.PubMedPubMedCentral
3.
Winsper C, Marwaha S, Lereya ST, Thompson A, Eyden J, Singh SP. Clinical and psychosocial outcomes of borderline personality disorder in childhood and adolescence: a systematic review. Psychol Med. 2015;45(11):2237–51.PubMed
4.
Wright AGC, Zalewski M, Hallquist MN, Hipwell AE, Stepp SD. Developmental trajectories of borderline personality disorder symptoms and psychosocial functioning in adolescence. J Personal Disord. 2016;30(3):351–72.
5.
Moran P, Romaniuk H, Coffey C, Chanen A, Degenhardt L, Borschmann R, et al. The influence of personality disorder on the future mental health and social adjustment of young adults: a population-based, longitudinal cohort study. Lancet Psychiatry. 2016;3(7):636–45.PubMed
6.
Winograd G, Cohen P, Chen H. Adolescent borderline symptoms in the community: prognosis for functioning over 20 years. J Child Psychol Psychiatry. 2008;49(9):933–41.PubMed
7.
Sio IT, Chanen AM, Killackey EJ, Gleeson J. The relationship between impulsivity and vocational outcome in outpatient youth with borderline personality features. Early Interv Psychiatry. 2011;5(3):249–53.PubMed
8.
9.
Soloff PH, Chiappetta L. 10-year outcome of suicidal behavior in borderline personality disorder. J Personal Disord. 2018;22:1–19.
10.
Alvarez-Tomás I, Soler J, Bados A, Martín-Blanco A, Elices M, Carmona C, et al. Long-term course of borderline personality disorder: a prospective 10-year follow-up study. J Personal Disord. 2017;31(5):590–605.
11.
Zanarini MC, Temes CM, Frankenburg FR, Reich DB, Fitzmaurice GM. Description and prediction of time-to-attainment of excellent recovery for borderline patients followed prospectively for 20 years. Psychiatry Res. 2018;262:40–5.PubMedPubMedCentral
12.
Caruana E, Farhall J, Cotton SM, Parrish E, van-der-El K, Davey CG, et al. Vocational engagement among young people entering mental health treatment compared with their general population peers. Early Interv Psychiatry. 2018. https://​doi.​org/​10.​1111/​eip.​12712.
13.
14.
Caruana E, Cotton SM, Farhall J, Parrish EM, Chanen A, Davey CG, et al. A comparison of vocational engagement among young people with psychosis, depression and borderline personality pathology. Community Ment Health J. 2017;54(6):831–41.PubMed
15.
Skodol AE, Gunderson JG, McGlashan TH, Dyck IR, Stout RL, Bender DS, et al. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Am J Psychiatry. 2002;159(2):276–83.PubMed
16.
17.
Thompson KN, Jackson H, Cavelti M, Betts J, McCutcheon L, Jovev M, et al. The clinical significance of subthreshold borderline personality disorder features in outpatient youth. J Personal Disord. 2018;23:1–11.
18.
Ostby KA, Czajkowski N, Knudsen GP, Ystrom E, Gjerde LC, Kendler KS, et al. Personality disorders are important risk factors for disability pensioning. Soc Psychiatry Psychiatr Epidemiol. 2014;49(12):2003–11.PubMedPubMedCentral
19.
Knudsen AK, Skogen JC, Harvey SB, Stewart R, Hotopf M, Moran P. Personality disorders, common mental disorders and receipt of disability benefits: evidence from the British National Survey of Psychiatric Morbidity. Psychol Med. 2012;42(12):2631–40.PubMed
20.
Zanarini MC, Jacoby RJ, Frankenburg FR, Reich DB, Fitzmaurice G. The 10-year course of social security disability income reported by patients with borderline personality disorder and axis II comparison subjects. J Personal Disord. 2009;23(4):346–56.
21.
Meuldijk D, McCarthy A, Bourke ME, Grenyer BFS. The value of psychological treatment for borderline personality disorder: systematic review and cost offset analysis of economic evaluations. PLoS One. 2017;12(3):e0171592.PubMedPubMedCentral
22.
van Asselt ADI, Dirksen CD, Arntz A, Severens JL. The cost of borderline personality disorder: societal cost of illness in BPD-patients. Eur Psychiatry. 2007;22(6):354–61.PubMed
23.
Salvador-Carulla L, Bendeck M, Ferrer M, Andión O, Aragonès E, Casas M, et al. Cost of borderline personality disorder in Catalonia (Spain). Eur Psychiatry. 2014;29(8):490–7.PubMed
24.
Wagner T, Fydrich T, Stiglmayr C, Marschall P, Salize H-J, Renneberg B, et al. Societal cost-of-illness in patients with borderline personality disorder one year before, during and after dialectical behavior therapy in routine outpatient care. Behav Res Ther. 2014;61:12–22.PubMed
25.
Katsakou C, Marougka S, Barnicot K, Savill M, White H, Lockwood K, et al. Recovery in Borderline Personality Disorder (BPD): a qualitative study of service users’ perspectives. PLoS One. 2012;7(5):e36517.PubMedPubMedCentral
26.
Jovev M, Jackson HJ. The relationship of borderline personality disorder, life events and functioning in an Australian psychiatric sample. J Personal Disord. 2006;20(3):205–17.
27.
Cristea IA, Gentili C, Cotet CD, Palomba D, Barbui C, Cuijpers P. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74(4):319–28.PubMed
28.
Fossey EM, Harvey CA. Finding and sustaining employment: a qualitative meta-synthesis of mental health consumer views. Can J Occup Ther. 2010;77(5):303–14.PubMed
29.
Strickler DC, Whitley R, Becker DR, Drake RE. First person accounts of long-term employment activity among people with dual diagnosis. Psychiatr Rehabil J. 2009;32(4):261–8.PubMed
30.
Killackey EJ, Jackson HJ, Gleeson J, Hickie IB, McGorry PD. Exciting career opportunity beckons! Early intervention and vocational rehabilitation in first-episode psychosis: employing cautious optimism. Aust N Z J Psychiatry. 2006;40(11–12):951–62.PubMed
31.
Harvey SB, Modini M, Christensen H, Glozier N. Severe mental illness and work: what can we do to maximise the employment opportunities for individuals with psychosis? Aust N Z J Psychiatry. 2013;47(5):421–4.PubMed
32.
Bond GR, Becker DR, Drake RE, Rapp CA, Meisler N, Lehman AF, et al. Implementing supported employment as an evidence-based practice. Psychiatr Serv. 2001;52(3):313–22.PubMed
33.
34.
35.
Drake RE, Bond GR, Becker DR. IPS principles. In: Individual placement and support. Oxford University Press; 2012. p. 33–45.
36.
37.
38.
Marshall T, Goldberg RW, Braude L, Dougherty RH, Daniels AS, Ghose SS, et al. Supported employment: assessing the evidence. Psychiatr Serv. 2014;65(1):16–23.PubMed
39.
Bond GR, Drake RE, Becker DR. Generalizability of the Individual Placement and Support (IPS) model of supported employment outside the US. World Psychiatry. 2012;11(1):32–9.PubMedPubMedCentral
40.
Modini M, Tan L, Brinchmann B, Wang M-J, Killackey E, Glozier N, et al. Supported employment for people with severe mental illness: systematic review and meta-analysis of the international evidence. Br J Psychiatry. 2016;209(1):14–22.PubMed
41.
42.
Metcalfe JD, Drake RE, Bond GR. Economic, labor, and regulatory moderators of the effect of Individual Placement and Support among people with severe mental illness: a systematic review and meta-analysis. Schizophr Bull. 2018;44(1):22–31.PubMed
43.
Rinaldi M, Perkins R, McNeil K, Hickman N, Singh SP. The Individual Placement and Support approach to vocational rehabilitation for young people with first episode psychosis in the UK. J Ment Health. 2010;19(6):483–91.PubMed
44.
Hegelstad WTV, ten Velden Hegelstad W, Joa I, Heitmann L, Johannessen JO, Langeveld J. Job- and school prescription: a local adaptation to individual placement and support for first episode psychosis. Early Interv Psychiatry. 2018. https://​doi.​org/​10.​1111/​eip.​12686.
45.
Killackey E, Cotton S. 93. Employment and education outcomes from a RCT of individual placement and support for young people with first-episode psychosis. Schizophr Bull. 2017;43(Suppl_1):S50–1.PubMedCentral
46.
Bond GR, Drake RE, Luciano A. Employment and educational outcomes in early intervention programmes for early psychosis: a systematic review. Epidemiol Psychiatr Sci. 2015;24(5):446–57.PubMed
47.
Ellison ML, Klodnick VV, Bond GR, Krzos IM, Kaiser SM, Fagan MA, et al. Adapting supported employment for emerging adults with serious mental health conditions. J Behav Health Serv Res. 2014;42(2):206–22.
48.
Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.PubMedPubMedCentral
49.
Chanen AM, McCutcheon L, Kerr IB. HYPE: a cognitive analytic therapy-based prevention and early intervention programme for Borderline Personality Disorder. In: Handbook of borderline personality disorder in children and adolescents. New York: Springer; 2014. p. 361–83.
50.
Ryle A, Kerr IB. Introducing cognitive analytic therapy: principles and practice. Chichester: Wiley; 2003. p. 286.
51.
Drake RE, Bond GR, Becker DR. Individual placement and support: an evidence-based approach to supported employment. Oxford: Oxford University Press; 2012. p. 191.
52.
Killackey E, Allott K, Woodhead G, Connor S, Dragon S, Ring J. Individual placement and support, supported education in young people with mental illness: an exploratory feasibility study. Early Interv Psychiatry. 2017;11(6):526–31.PubMed
53.
Burns T, Yeeles K, Langford O, Montes MV, Burgess J, Anderson C. A randomised controlled trial of time-limited individual placement and support: IPS-LITE trial. Br J Psychiatry. 2015;207(4):351–6.PubMed
54.
Killackey E, Allott K, Jackson HJ, Scutella R, Tseng Y-P, Borland J, et al. Individual placement and support for vocational recovery in first-episode psychosis: randomised controlled trial. Br J Psychiatry. 2019;214(2):76–82.
55.
Bond GR, Peterson AE, Becker DR, Drake RE. Validation of the Revised Individual Placement and Support Fidelity Scale (IPS-25). Psychiatr Serv. 2012;63(8):758–63.PubMed
56.
Richardson J, Iezzi A, Khan MA, Maxwell A. Validity and reliability of the Assessment of Quality of Life (AQoL)-8D Multi-Attribute Utility Instrument. Patient. 2013;7(1):85–96.PubMedCentral
57.
Arntz A, van den Hoorn M, Cornelis J, Verheul R, van den Bosch WMC, de Bie AJHT. Reliability and validity of the borderline personality disorder severity index. J Personal Disord. 2003;17(1):45–59.
58.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). Washington DC: American Psychiatric Pub; 2013. p. 991.
59.
Goldman HH, Skodol AE, Lave TR. Revising axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry. 1992;149(9):1148–56.PubMed
60.
Bohus M, Kleindienst N, Limberger MF, Stieglitz R-D, Domsalla M, Chapman AL, et al. The short version of the Borderline Symptom List (BSL-23): development and initial data on psychometric properties. Psychopathology. 2009;42(1):32–9.PubMed
61.
62.
Fossati A, Somma A, Borroni S, Markon KE, Krueger RF. The Personality Inventory for DSM-5 Brief Form: evidence for reliability and construct validity in a sample of community-dwelling Italian adolescents. Assessment. 2015;24(5):615–31.PubMed
63.
Sheehan KH, Sheehan DV. Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale. Int Clin Psychopharmacol. 2008;23(2):70–83.PubMed
64.
Ooi J, Michael J, Lemola S, Butterfill S, Siew CSQ, Walasek L. Interpersonal functioning in borderline personality disorder traits: a social media perspective. Sci Rep. 2020;10(1):1068.PubMedPubMedCentral
65.
Linder JR, Crick NR, Andrew Collins W. Relational aggression and victimization in young adults’ romantic relationships: associations with perceptions of parent, peer, and romantic relationship quality. Soc Dev. 2002;11(1):69–86.
66.
Chanen AM, Jackson HJ, McCutcheon LK, Jovev M, Dudgeon P, Yuen HP, et al. Early intervention for adolescents with borderline personality disorder using cognitive analytic therapy: randomised controlled trial. Br J Psychiatry. 2008;193(06):477–84.PubMed
67.
Chanen A, Jackson H, Cotton SM, Gleeson J, Davey CG, Betts J, et al. Comparing three forms of early intervention for youth with borderline personality disorder (the MOBY study): study protocol for a randomised controlled trial. Trials. 2015;16:476.PubMedPubMedCentral
68.
Dahl RE, Allen NB, Wilbrecht L, Suleiman AB. Importance of investing in adolescence from a developmental science perspective. Nature. 2018;554(7693):441–50.PubMed
69.
Sawyer SM, Azzopardi PS, Wickremarathne D, Patton GC. The age of adolescence. Lancet Child Adolesc Health. 2018;2(3):223–8.PubMed
70.
Ennals P, Fossey EM, Harvey CA, Killackey E. Postsecondary education: kindling opportunities for people with mental illness. Asia Pac Psychiatry. 2013;6(2):115–9.PubMed
Metadata
Title
INdividual Vocational and Educational Support Trial (INVEST) for young people with borderline personality disorder: study protocol for a randomised controlled trial
Authors
Andrew M. Chanen
Katie Nicol
Jennifer K. Betts
Gary R. Bond
Cathrine Mihalopoulos
Henry J. Jackson
Katherine N. Thompson
Martina Jovev
Hok Pan Yuen
Gina Chinnery
Judith Ring
Kelly Allott
Louise McCutcheon
Ashleigh P. Salmon
Eoin Killackey
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04471-3

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue

Study protocol

Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trial

Study protocol

Effects of school-based physical activity and multi-micronutrient supplementation intervention on growth, health and well-being of schoolchildren in three African countries: the KaziAfya cluster randomised controlled trial protocol with a 2 × 2 factorial design

Study protocol

Multi-dose Oral Ondansetron for Pediatric Gastroenteritis: study Protocol for the multi-DOSE oral ondansetron for pediatric Acute GastroEnteritis (DOSE-AGE) pragmatic randomized controlled trial

Letter

BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial

Letter

Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial

Research

Recruitment and retention of mothers of preschoolers and school-aged children in a social media-delivered healthy eating intervention: lessons learned from a randomized controlled trial